Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Pancreatic Cancer
Related studies linked through entity extraction aliases.
Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2